The European Association for Cancer Research
Advancing cancer research - from basic research to prevention, treatment and care
About EACR
The European Association for Cancer Research (EACR) was established in 1968 with the aim of advancing cancer research; from basic research to prevention, treatment and care. The Association is growing rapidly with a membership of over 6,000 laboratory, translational and clinical cancer researchers.
Meetings
EACR 20 in Lyon is the Association’s next main European meeting and takes place 5 - 8 July 2008. It will provide an outstanding scientific programme.
Click here to visit our Meetings page which links to information about the EACR20 conference and EACR Sponsored Meetings >
Fellowships and Bursaries
EACR fellowships give opportunities for researchers to work in exciting new contexts across Europe. They support research on the basis of technical exchange including participation in workshops and courses. Meeting bursaries are also awarded to support young researchers’ attendance at EACR’s main scientific meeting.
Newsletter and e-news bulletins
Our ‘Year Book’ is published annually in the spring and has reports on meetings, awards and fellowships, news from national society members, and other informative features. EACR members also receive weekly e-news bulletins containing valuable information about meetings and activities.
EACR Executive Committee and Council
Marco A Pierotti, President of EACR (pictured).
The Executive Committee conducts the affairs of the Association and is advised by national representatives on the EACR Council.
Executive Committee and Council membership can be found here >
Sustaining Members
Through Sustaining Membership, the European Association for Cancer Research forms valuable partnerships with selected organisations. Sustaining Members support the vital work of EACR in its fight against cancer and provide the means for the Association to develop.
Journals
EACR’s official journal is The European Journal of Cancer (EJC). Members enjoy significantly reduced subscription rates.
EACR Members may also take up a special Subscription rate to 'Clinical and Translational Oncology' alongside other offers from Springer.
Members also have free access to the current e-book edition of ‘European Oncological Disease’ from Touch Briefings.
Members Only
Log on to the Members Area. Keep your contact information up to date to make sure you never miss a weekly e-news bulletin or Newsletter mailing. Join or start a discussion in the Researchers Forum.
Join Today
Membership of EACR confers many benefits. Read more here and apply on-line.
Post-graduate students may apply for free membership.
Contact us
The EACR offices are hosted by the University of Nottingham, UK. Click here for the online contact form or to find full contact details >
Members' Log in
Latest News
EACR Members’ Survey 2008
If you missed the e-mail asking you to complete the 2008 EACR Members’ Survey, please visit the ‘View newsletters and publications’ page in the Members Area where there is a link to the questionnaire.
EACR-20 Registration - Members Late-Rate open until 2 June 2008
Registration is now open for EACR-20 with an excellent ‘late-rate’ for EACR Members. Late Rate payments must be made before 2 June 2008.
Keep contact details up to date to receive regular EACR news by e-mail and air-mail
Members' Items
How to apply for a Meeting Bursary to attend EACR-20
Meeting Bursary applications will be evaluated on 23 April 2008 and all applicants will be notified as soon as possible around the middle of May 2008.
Jobs and Study Opportunities
Postdoctoral position available
The package includes a competitive salary 36.000 euros/year, managerial and scientific training and a number of benefits.
IFOM-IEO Campus, Milan, Italy
For further information >Cancer Research Opportunities at IRCC (Italy) for post-docs and a junior P.I.
The Division of Molecular Oncology at the Institute for Cancer Research and Treatment (IRCC) invites applications for three post-doctoral positions, to study the function of Met and the semaphorins in cancer progression, with particular interest for identifying the implicated molecular mechanisms and developing molecular tools to target these pathways in human tumors. In addition, we welcome applications for one tenure-track position reserved to young independent investigators, with outstanding qualification in this field.
Post-Doctoral Position, The Immunotherapy & Gene Therapy Unit
The Immunotherapy & Gene Therapy Unit seeks a candidate with experience in immunology to study regulatory T cells expansion, conversion and inactivation in tumor bearers using a variety of mixed bone marrow chimeras as well as gene shut down in bone marrow donors.